Cargando…
Academic Cancer Center Phase I Program Development
Multiple factors critical to the effectiveness of academic phase I cancer programs were assessed among 16 academic centers in the U.S. Successful cancer centers were defined as having broad phase I and I/II clinical trial portfolios, multiple investigator‐initiated studies, and correlative science....
Autores principales: | Frankel, Arthur E., Flaherty, Keith T., Weiner, George J., Chen, Robert, Azad, Nilofer S., Pishvaian, Michael J., Thompson, John A., Taylor, Matthew H., Mahadevan, Daruka, Lockhart, A. Craig, Vaishampayan, Ulka N., Berlin, Jordan D., Smith, David C., Sarantopoulos, John, Riese, Matthew, Saleh, Mansoor N., Ahn, Chul, Frenkel, Eugene P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AlphaMed Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388388/ https://www.ncbi.nlm.nih.gov/pubmed/28314841 http://dx.doi.org/10.1634/theoncologist.2016-0409 |
Ejemplares similares
-
Development of cabozantinib for the treatment of prostate cancer
por: Vaishampayan, Ulka N
Publicado: (2014) -
The Year in Review for Renal Cancer
por: Vaishampayan, Ulka
Publicado: (2020) -
The power of meta-analysis in therapeutic decision making for advanced kidney cancer
por: Vaishampayan, Ulka
Publicado: (2019) -
Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study
por: Brown, Jennifer, et al.
Publicado: (2017) -
Predictors of Cytoreductive Nephrectomy for Metastatic Kidney Cancer in SEER and Metropolitan Detroit Databases
por: Vaishampayan, Ulka, et al.
Publicado: (2019)